Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres(®) Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma

PURPOSE: CalliSpheres(®) microspheres (CSM) are the first drug-eluting beads (DEB) developed in China. This study aimed to compare treatment response, survival, and safety profiles between DEB transarterial chemoembolization (DEB-TACE) with CSM and conventional TACE (cTACE) in huge hepatocellular ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xuhua, Liu, Juanfang, Han, Xinwei, Ren, Jianzhuang, Li, Hao, Li, Fengyao, Ju, Shuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814413/
https://www.ncbi.nlm.nih.gov/pubmed/35127501
http://dx.doi.org/10.3389/fonc.2021.793581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814413/
https://www.ncbi.nlm.nih.gov/pubmed/35127501
http://dx.doi.org/10.3389/fonc.2021.793581

Ejemplares similares